RadNet, Inc. (RDNT) income statement
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3050% above fair value
$69.51−2.31 (-3.22%)
Close on Nov 19, 2026Market cap $5.47BP/E –Yield –
RadNet, Inc. financial ratios
See a number that looks wrong?